Martine A Rothblatt, Chairperson & CEO at UNITED THERAPEUTICS, sold UTHR on Sep 11, 2026
Data as of Oct 16
- Traded
- Sep 11, 2026
- Disclosed
- Sep 14, 2026
- Filed
- 3 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
UTHR since disclosure
+6.1%
after the sale
Similar stocks (XLV) since disclosure
+5.3%
XLV — its sector index fund
Change in closing price from Sep 14, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$102Kdisclosed Sep 14 · filed 3 days after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$162Kdisclosed Sep 14 · filed 3 days after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$142Kdisclosed Sep 14 · filed 3 days after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$666Kdisclosed Sep 14 · filed 3 days after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$262Kdisclosed Sep 14 · filed 3 days after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$428Kdisclosed Sep 14 · filed 3 days after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$238Kdisclosed Sep 14 · filed 3 days after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$509Kdisclosed Sep 14 · filed 3 days after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$783Kdisclosed Sep 14 · filed 3 days after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$1.1Mdisclosed Sep 14 · filed 3 days after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$358Kdisclosed Sep 14 · filed 3 days after the trade